Estrogen receptor-alpha (ER-alpha) suppresses expression of its variant ER-alpha 36.
about
A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cellsAberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerEstrogen Signaling Modulates Allergic Inflammation and Contributes to Sex Differences in AsthmaThe therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumorsER-α36, a novel variant of ER-α, mediates estrogen-stimulated proliferation of endometrial carcinoma cells via the PKCδ/ERK pathway.Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling.Breast cancer cell growth inhibition by phenethyl isothiocyanate is associated with down-regulation of oestrogen receptor-alpha36Synuclein gamma stimulates membrane-initiated estrogen signaling by chaperoning estrogen receptor (ER)-alpha36, a variant of ER-alpha.Estrogen receptor-α36 is involved in pterostilbene-induced apoptosis and anti-proliferation in in vitro and in vivo breast cancerER-α36: a novel biomarker and potential therapeutic target in breast cancer.Estrogen receptor-alpha 36 mediates mitogenic antiestrogen signaling in ER-negative breast cancer cells.Alternate estrogen receptors promote invasion of inflammatory breast cancer cells via non-genomic signalingDisruption of the ER-α36-EGFR/HER2 positive regulatory loops restores tamoxifen sensitivity in tamoxifen resistance breast cancer cellsClassical estrogen receptors and ERα splice variants in the mouseEstrogen receptor α36 mediates a bone-sparing effect of 17β-estrodiol in postmenopausal women.Downregulation of ER-α36 expression sensitizes HER2 overexpressing breast cancer cells to tamoxifenA positive cross-regulation of HER2 and ER-α36 controls ALDH1 positive breast cancer cellsDehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cellslet-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor α signaling in breast cancer.GPR30 is necessary for estradiol-induced desensitization of 5-HT1A receptor signaling in the paraventricular nucleus of the rat hypothalamus.Involvement of ER-α36, Src, EGFR and STAT5 in the biphasic estrogen signaling of ER-negative breast cancer cellsA variant of estrogen receptor-alpha, ER-alpha36 is expressed in human gastric cancer and is highly correlated with lymph node metastasisOpposite effects of two estrogen receptors on tau phosphorylation through disparate effects on the miR-218/PTPA pathwayMammary epithelial cell phenotype disruption in vitro and in vivo through ERalpha36 overexpressionA summary of relationships between alternative splicing and breast cancer.A novel variant of ER-alpha, ER-alpha36 mediates testosterone-stimulated ERK and Akt activation in endometrial cancer Hec1A cells.Role of ER-α36 in breast cancer by typical xenoestrogens.Multiple receptors shape the estrogen response pathway and are critical considerations for the future of in vitro-based risk assessment efforts.Why (multi)targeting of cyclin-dependent kinases is a promising therapeutic option for hormone-positive breast cancer and beyond.Estrogen receptor profiling and activity in cardiac myocytes.Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells.Opposite regulation of estrogen receptor-α and its variant ER-α36 by the Wilms' tumor suppressor WT1.MicroRNA-335-5p and -3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance.Expression and function of a novel variant of estrogen receptor-α36 in murine airways.
P2860
Q24302285-8411F970-FD11-4DD1-9186-FF25715AD5A5Q26773907-853E99C9-D7B3-4B64-A072-1453B70F2E3AQ26774684-F7D92311-0BD1-481E-95D3-67059D8C95E5Q26829978-9017AD90-BF50-4C49-AC4C-5F7CABE9AF28Q33747888-915B7199-F9EB-43F2-8DBE-1286B2550E77Q33780210-8599CACE-357A-433D-9C31-38F668F53A2BQ33939078-7F1DCEBC-98DE-4864-ACD2-94133F63D4B5Q34033382-8F44E079-FF18-491C-AE80-9FA292A15739Q34050621-02622241-C3FE-40E4-952C-A5D62F5D72BBQ34140162-BF11A7A9-1577-44A3-ABBF-673C1F424528Q34140383-B5235C4F-5647-459F-A21D-8AF2E80D55C1Q34147662-CEAD7E65-6583-48A0-B06D-2D0A6DF9DBC4Q34156192-5FF00634-5C79-44C7-B28B-951B278189F7Q34936377-95C57A64-153E-498B-ADB0-C77E183DC0C5Q35229925-4B945BCD-2546-4A29-8A69-0265FEF39315Q35402408-60751D34-9115-4958-A01F-A91510579F8FQ35563328-EF797466-EFE5-4C4F-8FC4-78AC695C201FQ35860722-34300552-C107-404D-99D7-017367AF06E9Q35876772-9A9C1A86-4903-47F6-95DD-E0D160F4A3D8Q35928422-BA25F93C-AAC7-4BFA-820B-EC4B70D2ACE1Q36049034-445B9961-3A94-4862-A20D-3331C894E85CQ36049050-605FEFEB-4D0C-4BD7-A7E5-A28AEC85329AQ36057659-7DE74DBD-DD43-4668-8F32-92CAD2DBFB88Q36310690-3DA74E0A-56B1-436A-8BEF-863EAD698034Q36378283-86039B23-CA67-4C3F-99A9-7F54718B4403Q37387466-AC76666D-09C5-4EB4-A40E-39A65A480A5FQ38580235-6CDC57DB-D51E-4EB8-9E59-2E9D7217B380Q38663074-E4691937-6719-4DB0-B99C-A1B1D31153E5Q38675849-64EBB00B-1EDF-4ABF-B833-AC343CB09975Q39778698-2125F18A-B427-40DB-ADC3-E016C6B0DF98Q41134570-D2A20A8E-F691-4DC6-A883-AC0C5E5F6C47Q41975840-4B419D33-0F1D-4C26-85A7-7292CB5627BBQ51068524-35E40D63-E14B-4560-BBAE-5F512AC162CDQ51454607-50F46E8E-5647-4BE9-AF99-B256A88AD837
P2860
Estrogen receptor-alpha (ER-alpha) suppresses expression of its variant ER-alpha 36.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Estrogen receptor-alpha (ER-alpha) suppresses expression of its variant ER-alpha 36.
@en
Estrogen receptor-alpha
@nl
type
label
Estrogen receptor-alpha (ER-alpha) suppresses expression of its variant ER-alpha 36.
@en
Estrogen receptor-alpha
@nl
prefLabel
Estrogen receptor-alpha (ER-alpha) suppresses expression of its variant ER-alpha 36.
@en
Estrogen receptor-alpha
@nl
P2093
P2860
P1433
P1476
Estrogen receptor-alpha (ER-alpha) suppresses expression of its variant ER-alpha 36.
@en
P2093
Megan Coleman
Zhaoyi Wang
P2860
P304
P356
10.1016/J.FEBSLET.2009.03.047
P407
P577
2009-03-26T00:00:00Z